Deciphering the scopolamine challenge rat model by preclinical functional MRI
Abstract During preclinical drug testing, the systemic administration of scopolamine (SCO), a cholinergic antagonist, is widely used. However, it suffers important limitations, like non-specific behavioural effects partly due to its peripheral side-effects. Therefore, neuroimaging measures would enh...
Guardado en:
Autores principales: | Gergely Somogyi, Dávid Hlatky, Tamás Spisák, Zsófia Spisák, Gabriella Nyitrai, András Czurkó |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc375befec4241b7a5e689a909becee5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data
por: Matthias Zunhammer, et al.
Publicado: (2021) -
Effect of Scopolamine-based Amnesia on the Number of Astrocytes in the Rat's Hippocampus
por: Jahanshahi,M, et al.
Publicado: (2012) -
Scopolamine Reduces the Density of M1 Muscarinic Neurons in Rats' Hippocampus
por: Jahanshahi,M, et al.
Publicado: (2013) -
The Evaluation of Amnesia Induced by Scopolamine on the Astrocytes Number in Rats Dentate Gyrus
por: N Azami, et al.
Publicado: (2012) -
D-cycloserine in prelimbic cortex reverses scopolamine-induced deficits in olfactory memory in rats.
por: Marta Portero-Tresserra, et al.
Publicado: (2013)